PT1231910E - Pentamidina para tratar o cancro - Google Patents

Pentamidina para tratar o cancro Download PDF

Info

Publication number
PT1231910E
PT1231910E PT00975725T PT00975725T PT1231910E PT 1231910 E PT1231910 E PT 1231910E PT 00975725 T PT00975725 T PT 00975725T PT 00975725 T PT00975725 T PT 00975725T PT 1231910 E PT1231910 E PT 1231910E
Authority
PT
Portugal
Prior art keywords
endo
exonuclease
compounds
activity
cancer
Prior art date
Application number
PT00975725T
Other languages
English (en)
Portuguese (pt)
Inventor
Terry Chow
Chiaoli Yeh
David Griller
Leonard Yuen
Original Assignee
Oncozyme Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncozyme Pharma Inc filed Critical Oncozyme Pharma Inc
Publication of PT1231910E publication Critical patent/PT1231910E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT00975725T 1999-11-16 2000-11-16 Pentamidina para tratar o cancro PT1231910E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16568899P 1999-11-16 1999-11-16

Publications (1)

Publication Number Publication Date
PT1231910E true PT1231910E (pt) 2009-08-06

Family

ID=22600019

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00975725T PT1231910E (pt) 1999-11-16 2000-11-16 Pentamidina para tratar o cancro

Country Status (12)

Country Link
US (2) US20060276548A1 (enExample)
EP (1) EP1231910B1 (enExample)
JP (1) JP2003515534A (enExample)
AT (1) ATE431734T1 (enExample)
AU (1) AU780538B2 (enExample)
CA (1) CA2388674C (enExample)
CY (1) CY1110503T1 (enExample)
DE (1) DE60042245D1 (enExample)
DK (1) DK1231910T3 (enExample)
ES (1) ES2327313T3 (enExample)
PT (1) PT1231910E (enExample)
WO (1) WO2001035935A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097794A2 (en) * 2000-06-21 2001-12-27 Georgetown University Inhibitors of matriptase for the treatment of cancer
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6693125B2 (en) 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
US8053477B2 (en) * 2002-03-29 2011-11-08 University Of Maryland, Baltimore Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same
ITMI20021455A1 (it) * 2002-07-02 2004-01-02 Ugo Raffaello Citernesi Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico
US20050054708A1 (en) * 2003-07-28 2005-03-10 Nichols Matthew James Combinations of drugs for the treatment of neoplasms
CA2561513C (en) 2004-03-29 2019-02-26 University Of South Florida Effective treatment of tumors and cancer with triciribine and related compounds
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
EP1832293A4 (en) * 2004-12-10 2009-01-07 Tmrc Co Ltd MEANS FOR THE TREATMENT OF CANCER METASTAS AND CANNESMAS TREATMENT
WO2009086485A1 (en) 2007-12-28 2009-07-09 Server Technology, Inc. Power distribution, management, and monitoring systems and methods
EP2424516A4 (en) * 2009-05-01 2014-04-02 Oncozyme Pharma Inc PENTAMIDINE COMBINATIONS FOR THE TREATMENT OF CANCER
WO2014008592A1 (en) * 2012-07-13 2014-01-16 Oncozyme Pharma Inc. Combinations comprising diamidine compounds and parp inhibitors for use iν treating cancer
US11103468B2 (en) 2017-11-16 2021-08-31 Montdorex Inc. Mono- and di-amidine endo-exonuclease inhibitors and methods for inhibiting endo-exonuclease activity
CN111671904B (zh) * 2020-04-15 2022-12-06 四川大学华西第二医院 一种含有抑制核酸内切酶功能的药物及其抗肿瘤的用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2145528C3 (de) * 1971-09-11 1981-12-17 Heinrich Mack Nachf., 7918 Illertissen Exonuclease und diese enthaltendes cytostatisches Mittel
EP0257406B2 (en) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
US5166140A (en) * 1987-05-05 1992-11-24 City Of Hope Use of certain nucleoside analogs to attenuate cancer cell resistance to DNA damaging chemotherapy
US5585363A (en) * 1987-05-05 1996-12-17 City Of Hope Circumvention of human tumor drug resistance
US4856528A (en) * 1987-06-26 1989-08-15 John Hopkins University Tumor volume determination
US5204352A (en) * 1987-09-29 1993-04-20 The United States Of America As Represented By The Secretary Of The Army Compounds exhibiting anti-parasitic activity and a method for their use
US5084480A (en) * 1987-11-06 1992-01-28 Fujisawa Usa, Inc. Pentamidine salts useful in the treatment of pneumocystis carinii pneumonia
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
MX16687A (es) * 1988-07-07 1994-01-31 Ciba Geigy Ag Compuestos de biarilo y procedimiento para su preparacion.
US5037758A (en) * 1989-01-11 1991-08-06 Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada Enhanced production of biosurfactant through the use of a mutated B subtilis strain
GB8903438D0 (en) * 1989-02-15 1989-04-05 May & Baker Ltd New compositions of matter
US5352581A (en) * 1989-03-24 1994-10-04 United States/National Institutes Of Health Sensitive yeast genetic system for identifying agents causing double-stranded DNA damage
WO1991009954A1 (en) * 1989-12-27 1991-07-11 Resnick Michael A Novel system for isolating and producing new genes, gene products and dna sequences
US5489524A (en) * 1991-03-26 1996-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric protein that has a human Rho motif and deoxyribonuclease activity
US5324830A (en) * 1991-03-26 1994-06-28 United States Of America Chimeric protein that has a human RHo Motif and deoxyribonuclease activity
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
US5723288A (en) * 1994-05-06 1998-03-03 The University Of North Carolina At Chapel Hill Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans, and kits useful therefor
US5874283A (en) * 1995-05-30 1999-02-23 John Joseph Harrington Mammalian flap-specific endonuclease
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
US5916779A (en) * 1995-09-21 1999-06-29 Becton, Dickinson And Company Strand displacement amplification of RNA targets
US5935982A (en) * 1997-02-28 1999-08-10 The University Of North Carolina At Chapel Hill Methods of treating retroviral infection and compounds useful therefor
US5977311A (en) * 1997-09-23 1999-11-02 Curagen Corporation 53BP2 complexes
KR100631766B1 (ko) * 1997-10-07 2006-10-09 오노 야꾸힝 고교 가부시키가이샤 폴리펩티드, 그 폴리펩티드를 암호화하는 ｃＤＮＡ 및그들의 용도
US7115665B1 (en) * 2000-11-16 2006-10-03 Onocozyme Pharma, Inc. Inhibitors of endo-exonuclease activity for treating cancer
EP1263942B1 (en) * 2000-03-08 2013-11-06 Novozymes A/S Variants with altered properties
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
US20040010045A1 (en) * 2001-09-07 2004-01-15 Taolin Yi Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
US8053477B2 (en) * 2002-03-29 2011-11-08 University Of Maryland, Baltimore Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same

Also Published As

Publication number Publication date
US20060276548A1 (en) 2006-12-07
AU780538B2 (en) 2005-03-24
ATE431734T1 (de) 2009-06-15
DK1231910T3 (da) 2009-08-31
US20090068094A1 (en) 2009-03-12
EP1231910A2 (en) 2002-08-21
CA2388674C (en) 2005-01-25
DE60042245D1 (de) 2009-07-02
WO2001035935A3 (en) 2002-01-03
CA2388674A1 (en) 2001-05-25
ES2327313T3 (es) 2009-10-28
JP2003515534A (ja) 2003-05-07
WO2001035935A2 (en) 2001-05-25
EP1231910B1 (en) 2009-05-20
WO2001035935B1 (en) 2002-02-07
AU1376501A (en) 2001-05-30
CY1110503T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
CY1110503T1 (el) Πενταμιδινη για θεραπεια καρκινου
WO2007103114A3 (en) Notch inhibition in the treatment or prevention of atherosclerosis
WO2004043374A3 (en) Methods and compositions for treating cancer using proteasome inhibitors
IL245146A0 (en) Phosphatidyl-inositol 3-kinase delta inhibitors
EP2308963A3 (en) System for processing lipoaspirate cells
AU2003256755A8 (en) Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations
ATE362363T1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
BRPI0413745A (pt) horário mde dosagem para agentes anticancerìgenos erbb2
UA92348C2 (en) 17b-HSD1 AND STS INHIBITORS
ATE497763T1 (de) Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
Assanelli et al. Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients
KR20170010019A (ko) 방사선 및 화학적 손상으로부터 보호하기 위한 세코이솔라리시레시놀 디글루코사이드(ｓｄｇ) 및 관련 화합물의 용도
DE60309887D1 (de) Kombination von einem aromatasehemmer mit einem bisphosphonat
BR0311136A (pt) composto ou um sal, enanciÈmero, diaestereÈmero ou éster hidrolisável in vivo ou mistura dos mesmos farmaceuticamente aceitável, composição, e, método para inibir a atividade de fator letal (lf) liberado de bactérias em um mamìfero
PL1889920T3 (pl) Sposób identyfikacji związków do terapii antynowotworowej in vitro
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
WO2000057871A3 (en) Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof
DE602004022423D1 (de) Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz
DE69838002D1 (de) Substituierte 11-phenyl-dibenzazepin-verbindungen, die nützlich sind zur behandlung oder vorbeugung von durch abnormale zellproliferation gekennzeichneten krankheiten
ATE311901T1 (de) Verwendung von tgf-beta inhibitoren zur behandlung von cerebralen krankheiten
Alimdjanovich EFFICACY OF ANTIOXIDANT COMPLEX THERAPY IN RESTORING PERIODONTAL TISSUES IN WORKERS EXPOSED TO STYRENE
CONNECTIVE " XVIII VV Podvysotskiy Readings
PT1455772E (pt) Remédio para o tratamento radical de tumores, de processos inflamatórios, infecções fúngicas e outras alterações dos tecidos, diagnóstico e profilaxia, e método e sua aplicação
Giudici et al. 28 In vivo testing of irreversible aromatase inhibitors in the rat
HK1119962A (en) Reduction of side effects from aromatase inhibitors used for treating breast cancer